QTLs in Region (mRatBN7.2)
1300114 | Srn2 | Serum renin concentration QTL 2 | 3.27 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 14 | 3813074 | 21217635 | Rat |
631528 | Scl11 | Serum cholesterol level QTL 11 | 4.9 | | blood cholesterol amount (VT:0000180) | blood total cholesterol level (CMO:0000051) | 14 | 17573412 | 19726296 | Rat |
1581500 | Renag1 | Renal agenesis QTL 1 | | | kidney development trait (VT:0000527) | percentage of study population developing unilateral renal agenesis during a period of time (CMO:0000940) | 14 | 8170668 | 68298175 | Rat |
731183 | Pia20 | Pristane induced arthritis QTL 20 | 3.55 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 14 | 9088978 | 39057237 | Rat |
631212 | Bw5 | Body weight QTL5 | 5.43 | | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 14 | 11030812 | 30320092 | Rat |
2302277 | Gluco38 | Glucose level QTL 38 | 5.8 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 14 | 11030622 | 28035204 | Rat |
1331740 | Bw26 | Body weight QTL 26 | 3.028 | | body mass (VT:0001259) | body weight (CMO:0000012) | 14 | 3813074 | 30767156 | Rat |
619619 | Rf4 | Renal disease susceptibility QTL 4 | 4.1 | 0.002 | urine total protein amount (VT:0000032) | urine protein excretion rate to body weight ratio (CMO:0001099) | 14 | 1 | 32754612 | Rat |
1358296 | Ael3 | Aortic elastin QTL 3 | 3.7 | 0.00051 | aorta elastin amount (VT:0003905) | aortic elastin | 14 | 8267090 | 53267090 | Rat |
71117 | Niddm17 | Non-insulin dependent diabetes mellitus QTL 17 | 2.35 | | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 14 | 17593761 | 42336881 | Rat |
70195 | Mcs8 | Mammary carcinoma susceptibility QTL 8 | 4.28 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 14 | 3813074 | 24531477 | Rat |
2300183 | Bmd60 | Bone mineral density QTL 60 | 5.7 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 14 | 1 | 26541967 | Rat |
631839 | Niddm37 | Non-insulin dependent diabetes mellitus QTL 37 | 3.37 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 14 | 11030622 | 95876975 | Rat |
631262 | Tcas4 | Tongue tumor susceptibility QTL 4 | 7.29 | | tongue integrity trait (VT:0010553) | number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) | 14 | 17622561 | 42337007 | Rat |
634352 | Apr6 | Acute phase response QTL 6 | 3.7 | | blood interleukin-6 amount (VT:0008595) | plasma interleukin-6 level (CMO:0001927) | 14 | 1 | 41131407 | Rat |
2300159 | Bmd61 | Bone mineral density QTL 61 | 5.3 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 14 | 1 | 26541967 | Rat |
2302045 | Pia39 | Pristane induced arthritis QTL 39 | 4.9 | 0.001 | blood immunoglobulin amount (VT:0002460) | serum immunoglobulin G2a level (CMO:0002116) | 14 | 8267090 | 53267090 | Rat |
1300140 | Srn3 | Serum renin concentration QTL 3 | 3.19 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 14 | 14875168 | 30883947 | Rat |